Clinical and Angiographic Predictors of No‐Reflow and Its Impact on Outcomes in ST‐Elevation Myocardial Infarction: A Retrospective Study
Clinical Cardiology · 2026-06 · 49 (6)
DOI: 10.1002/clc.70374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 15.06.2026. Verfasst von Husnain Bashir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Coronary Angiography, No-Reflow Phenomenon, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To identify clinical and angiographic predictors of the no‐reflow phenomenon and evaluate its impact on short‐ and long‐term outcomes in patients undergoing primary percutaneous coronary intervention (PCI) for ST‐elevation myocardial infarction (STEMI).
Methods
This retrospective study included 2925 patients who underwent primary PCI for STEMI between January 2020 and July 2025. Patients were stratified into no‐reflow and normal flow groups based on final TIMI flow. Baseline clinical, angiographic, and procedural data were analyzed. Multivariate logistic regression identified independent predictors of no‐reflow.
Results
The no‐reflow phenomenon occurred in 526 patients (18%). Independent predictors included older age, diabetes mellitus, Killip class ≥ II, high thrombus burden, pre‐PCI TIMI 0 flow, and longer symptom‐to‐door time. Use of GP IIb/IIIa inhibitors was protective. No‐reflow patients had higher in‐hospital mortality (17.3% vs. 4.5%), lower LVEF, and increased 1‐year MACE (40.5% vs. 16.4%). Kaplan–Meier curves confirmed significantly reduced MACE‐free survival (log‐rank p < 0.001).
Conclusion
The no‐reflow phenomenon is associated with adverse outcomes and can be predicted using routine clinical and angiographic features. Early identification may enable targeted preventive strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan.
- Department of Cardiology, Abbas Institute of Medical Sciences, Muzaffarabad, Pakistan.
ORCID-Profile: Jahanzeb Malik, Abida Perveen
Zitieren
APA
Bashir, H., Berkha, F. N. U., Malik, J., & Perveen, A. (2026). Clinical and Angiographic Predictors of No‐Reflow and Its Impact on Outcomes in ST‐Elevation Myocardial Infarction: A Retrospective Study. Clinical Cardiology, 49(6). https://doi.org/10.1002/clc.70374
Vancouver
Bashir H, Berkha FNU, Malik J, Perveen A. Clinical and Angiographic Predictors of No‐Reflow and Its Impact on Outcomes in ST‐Elevation Myocardial Infarction: A Retrospective Study. Clinical Cardiology. 2026;49(6). doi:10.1002/clc.70374
BibTeX
@article{Bashir2026,
author = {Bashir, Husnain and Berkha, F N U and Malik, Jahanzeb and Perveen, Abida},
title = {Clinical and Angiographic Predictors of No‐Reflow and Its Impact on Outcomes in ST‐Elevation Myocardial Infarction: A Retrospective Study},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {6},
doi = {10.1002/clc.70374}
}
EUVIMED